IND Filing and Concurrent RMAT Request Position XytriX™ as a Potential Breakthrough Biotherapeutic for More Than 500 ...
Episcopal Health Services announced on Tuesday, March 24, that it is now offering low-dose radiotherapy using its new ...
During their lifetime, one in two women and one in four men will experience hand osteoarthritis, a disabling condition that can result in pain, joint stiffness, functional limitations, and sometimes ...
Osteoarthritis, a degenerative bone disorder, causes persistent discomfort, function loss, and joint damage. The worldwide aging trend and a lack of effective medicines are driving up demand for ...
In this second installment of our stories on osteoarthritis, we discuss a new approach for treatment and cure. Both stories are part of our series on regenerative medicine. We define regenerative ...
Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most ...
Siemens Healthineers announced that its Varian TrueBeam radiotherapy systems, which include TrueBeam, TrueBeam STx, VitalBeam ...
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have created a promising injectable cell therapy to treat osteoarthritis that both reduces inflammation and also regenerates ...
GlobalData on MSN
FDA clears Varian’s TrueBeam systems for low-dose radiation therapy in osteoarthritis
Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, MFOMA. Osteoarthritis is the most common form of arthritis, affecting more than 32.5 million adults in the United States. Osteoarthritis is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results